Biocompatibility evaluation of breathing gas pathways in healthcare applications — Part 1: Evaluation and testing within a risk management process
文件核验信息(付费前可核对)
标准范围(官方英文摘要)
This document specifies:
— the general principles governing the biological evaluation within a risk management process of the gas pathways of a medical device, its parts or accessories, which are intended to provide respiratory care or supply substances via the respiratory tract to a patient in all environments;
— the general categorization of gas pathways based on the nature and duration of their contact with the gas stream;
— the evaluation of existing relevant data from all sources;
— the identification of gaps in the available data set on the basis of a risk analysis;
— the identification of additional data sets necessary to analyse the biological safety of the gas pathway;
— the assessment of the biological safety of the gas pathway.
This document covers general principles regarding biocompatibility assessment of medical device materials, which make up the gas pathway, in normal use and normal condition. This document does not cover biological hazards arising from mechanical damage.
The other parts of ISO 18562 cover specific tests that address potentially hazardous substances that are added to the respirable gas stream and establish acceptance criteria for these subst
标准信息
- 标准号
- ISO 18562-1:2024
- 英文标题
- Biocompatibility evaluation of breathing gas pathways in healthcare applications — Part 1: Evaluation and testing within a risk management process
- 发布单位
- —
- 技术委员会
- ISO/TC 121/SC 3
- 版本 / 版次
- 2
- 状态
- 现行
- 发布日期
- 2024
- ICS 分类
- 11.040.10 麻醉、呼吸和复苏设备
- 页数
- 34 页
- 官方定价
- CHF 151
同分类下的其他标准
相关标准
怎么获取 ISO 18562-1:2024 全文
这份标准属于 ISO/IEC 发布,全文 34 页,语言为 EN。如果你只需要核对条款、做合规对照或者写方案引用,直接在线支付 2 元即可获得 PDF 全文,支付成功后立即给出下载链接(24 小时内有效,之后凭购买记录也能随时重新下载,不再收费)。
如果你要长期、大量使用这类标准,包年会员更合适:39 元一年每天可下 10 份,69 元一年每天 50 份,999 元一年不限次数。会员下载过的标准可以随时免费重下,不占用每日次数。按单份均价 3 元估算,一年下 13 份以上就已经回本。
需要注意的是,标准正文的著作权归 ISO、IEC 及各国家成员体所有。本站提供的是文献检索与代传服务,建议在正式项目、投标或认证场景中同时通过官方渠道核验标准的最新版本,避免使用已废止版本造成合规风险。